Tag: life sciences
-
Intermountain, deCode Partner on Population Genetics
A health care network in Utah is partnering with a genetic analytics company to find connections between genetics and disease in 500,000 of its members.
-
Antibiotics Synthesized from Scorpion Venom
Biochemistry labs in the U.S. and Mexico isolated and synthesized key compounds from scorpion venom that kills bacteria resistant to antibiotics.
-
Patch Performs Fast DNA Collection for Plant Diseases
A small patch with tiny needles collects DNA from leaves in about one minute, making possible portable devices to detect plant diseases.
-
DoD Funding Vaccine, Therapy Delivery Device
The U.S. Department of Defense is supporting creation of a small, portable device that safely sends vaccines and therapies through the skin.
-
Engineered Antibody Delays Type 1 Diabetes Onset
Results from a clinical trial show a synthetic antibody delayed for about 2 years the start of type 1 diabetes symptoms among people at high risk of the disease.
-
Repurposing an Anti-Inflammatory Drug to Treat a Life-Threatening Disease
Researchers successfully identified a common drug compound, a non-steroidal anti-inflammatory, that is active against all growing stages of the parasite that causes schistosomiasis.
-
Gut Microbe Links to Autism Revealed
Lab mice with bacteria transplanted from human intestines show signs that autism behaviors may result from the state of their gut microbes.
-
Strep A Vaccine Project Launched
An international initiative is underway to begin work on a vaccine against group A streptococcus infections becoming resistant to today’s antibiotics.
-
Liquid Biopsy Screening Start-Up Launches, Gains $110M
A new enterprise is starting up, developing early-stage cancer screening with a single blood test, based on research at Johns Hopkins University.
-
Synthetic Cannabidiol Shown to Reduce Seizures
A synthetic form of cannabidiol, or CBD, a derivative of cannabis, is shown in tests with lab rats to reduce the occurrence of seizures from epilepsy.